ESPR EBITDA Margin
Esperion Therapeutics Inc · EBITDA Margin
ESPR EBITDA Margin
Latest reported9.54%period ending
ESPR TTM EBITDA Margin (-649598.00% → 9.54%)
TTM ebitda margin
High-resolution chart · PNG
ESPR ebitda margin history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Margin |
|---|---|
| 9.5396% | |
| 15.8428% | |
| -8.9976% | |
| -12.1193% | |
| -34.0847% | |
| 2.4092% | |
| -9.6145% | |
| -14.4783% | |
| -11.9152% | |
| -129.0319% | |
| -145.6658% | |
| -187.143% | |
| -223.6488% | |
| -233.6522% | |
| -259.262% | |
| -298.6338% | |
| -203.7982% | |
| -283.1759% | |
| -365.9567% | |
| -468.1506% | |
| -55.2106% | |
| -52.8831% | |
| -37.7677% | |
| -30.8338% | |
| -5,227.7534% | |
| -60.1062% | |
| -27.5481% | |
| -23.2641% | |
| -20.9844% | |
| -110.0746% | |
| -2,757,300% | |
| -1,412,150% | |
| -900,733.3333% | |
| -712,025% | |
| -709,400% | |
| -649,598% |